Hunter C, Jensen J, Imeah B, McCarron M, Clark M. A retrospective cost-effectiveness analysis of mifepristone–misoprostol medical abortions in the first year at the Regina General Hospital. J Obstet Gynaecol Canada. 2021 Feb 1;43(2):211-8.

Wiebe ER, Campbell M, Ramasamy H, Kelly M. Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol. Contraception: X. 2020 Jan 1;2:100023.

Chen M, Lindley A, Kimport K, Dehlendorf C. An in-depth analysis of the use of shared decision making in contraceptive counseling. Contraception. 2019 Mar 1;99(3):187-91.

Wiebe ER, Trouton KJ, Dicus J. Motivation and experience of nulliparous women using intrauterine contraceptive devices. J Obstet Gynaecol Can. 2010 Apr;32(4):335-8.

Wiebe ER. Methotrexate with or without misoprostol to terminate pregnancies with no gestational sac visible by ultrasound. Int J Gynaecol Obstet. 2009 May 20.

Wiebe ER, Adams L. Women’s perceptions about seeing the ultrasound picture before an abortion. Eur J Contracept Reprod Health Care. 2009 Apr;14(2):97-102.

Wiebe ER, Adams LC. Women’s experience of viewing the products of conception after an abortion. Contraception. 2009 Dec;80(6):575-7. Epub 2009 Aug 22.

Wiebe ER, Trussell J. Contraceptive failure related to estimated cycle day of conception relative to the start of the last bleeding episode. Contraception. 2009 Mar;79(3):178-81.

Wiebe ER, Trouton K, Fang ZA. Comparing Continuation rates and side effects of hormonal contraceptives in East Asian and Caucasian women after abortion. Contraception. 2008 Nov;78(5):405-8.

Wiebe ER, Sandhu S Access to abortion: what women want from abortion services. J Obstet Gynaecol Can. 2008 Apr;30(4):327-31.

Wiebe E, Hempstock W. Comparison of four regimens of misoprostol after methotrexate for early abortion. Epub 2008 Mar 4.

Wiebe E. A 15-year-old Chinese IUD.  Int J Gynaecol Obstet. 2008 May;101(2):192-3.

Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, Winikoff B. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet. 2007 Mar;96(3):212-8. Epub 2007 Feb 5.

Wiebe ER, Trouton KJ, Lima R. Misoprostol alone vs. methotrexate followed by misoprostol for early abortion. Int J Gynaecol Obstet. 2006 Dec;95(3):286-7. Epub 2006 Sep 25.

Wiebe ER, Trouton KJ, Eftekhari A. Anemia in early pregnancy among Canadian women presenting for abortion. Int J Gynaecol Obstet. 2006 Jul;94(1):60-1. Epub 2006 May 6.

Wiebe ER, Henderson A, Choi J, Trouton K. Ethnic Korean women’s perceptions about birth control. Contraception. 2006 Jun;73(6):623-7. Epub 2006 Apr 17.

Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, Winikoff B. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG. 2006 Jun;113(6):621-8.

Wiebe ER, Trouton KJ, Savoy E. Intra-cervical versus i.v. fentanyl for abortion. Hum Reprod. 2005 Jul;20(7):2025-8. Epub 2005 Apr 14.

Wiebe E, Fowler D, Trouton K, Fu N. Comparing patients’ telephone calls after medical and surgical abortions. Contraception. 2006 Mar;73(3):271-3. Epub 2005 Oct 19

Wiebe ER, Trouton KJ, Fielding SL, Klippenstein J, Henderson A Antichoice attitudes to abortion in women presenting for medical abortions. J Obstet Gynaecol Can. 2005 Mar;27(3):247-50.

Wiebe ER, Trouton KJ, Fielding SL, Grant H, Henderson A. Anxieties and attitudes towards abortion in women presenting for medical and surgical abortions. J Obstet Gynaecol Can. 2004 Oct;26(10):881-5.

Wiebe ER, Janssen PA, Henderson A, Fung I. Ethnic Chinese women’s perceptions about condoms, withdrawal and rhythm methods of birth control. Contraception. 2004 Jun;69(6):493-6.

Wiebe ER, Trouton K. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion Contraception. 2004 Dec;70(6):463-6.

Wiebe E, Guilbert E, Jacot F, Shannon C, Winikoff B. A fatal case of Clostridium sordellii septic shock syndrome associated with medical abortion. J Obstet Gynecol 2004; 104:1142-4.

Wiebe E, Podhradsky L, Dijak V. The effect of lorazepam on pain and anxiety in abortion. Contraception. 2003 Mar;67(3):219-21.

Wiebe ER, Sent L, Fong S, Chan J. Barriers to use of oral contraceptives in ethnic Chinese women presenting for abortion. Contraception 2002;65:159-63.

Wiebe E, Dunn S, Guilbert E, Jacot F, Lugtig L. Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol. Obstet Gynecol. 2002 May;99(5 Pt 1):813-9.

Wiebe ER. Pain control in medical abortion. Int J Gynecol Obstet 2001;74:275-80.

Trussell J, Wiebe E, Shochet T, Guilbert E. Cost savings from emergency contraceptive pills in Canada. Obstet Gynecol 2001;97:

Wiebe ER, Janssen PJ. Universal screening for domestic violence in abortion. Women’s Health Issues 2001;11:436-41.

Wiebe ER. Misoprostol administration in medical abortion. A comparison of three regimens. J. Reprod Med 2001;46(2):125-9.

Rawling MJ, Wiebe ER. Randomized controlled trial of fentanyl for abortion pain. Am J Obstet Gynecol 2001;185:103-7.

Wiebe ER, Janssen PJ. Time lost from work among women choosing medical or surgical abortions. Women’s Health Issues 2000;10:327-32.

Wiebe ER, Switzer P. Arteriovenous malformations of the uterus associated with medical abortion. Int J Gynecol Obstet 2000;71:155-8.

Wiebe ER. A randomized trial of aromatherapy to reduce anxiety before abortion. Effect Clin Pract 2000;4:166-9.

Wiebe ER, Comay S, McGregor MJ, Ducceschi S. Offering HIV prophylaxis to sexual assault victims – sixteen months experience in a sexual assault service. Can Med Assoc J 2000;162:641-5.

Wiebe ER, Janssen P, Hales S. Time lost from work in women choosing medical or surgical abortions. J Am Med Women’s Assoc 2000;55:202.

McGregor MJ, Wiebe ER, Marion SA, Livingstone C. Why don’t women report sexual assault to police?: 5 years of data from the Vancouver Sexual Assault Service. Can Med Assoc J 2000;162:659-60.

Wiebe ER, Janssen PJ. Women’s experiences with conservative management of spontaneous abortions. Can Fam Phys 1999;45:2355-60.

Wiebe ER. Tamoxifen compared to methotrexate when used with misoprostol for abortion. Contraception 1999;59:265-70.

Wiebe ER, Janssen PJ. Reducing surgery in management of spontaneous abortion by family doctors. Can Fam Phys 1999;45:2364-9.

Wiebe ER. Oral methotrexate compared to injected methotrexate when used with misoprostol for abortion. Am J Obstet Gynecol 1999;181:149-52.

McGregor MJ, Le G, Marion SA, Wiebe ER. Examination for sexual assault: Is the presence of documented physical injury associated with charge laying? CMAJ 1999;160:1565-9.

Creinin M, Wiebe E, Gold M. Methotrexate and misoprostol for early abortion in adolescent women. J Ped Adolesc Gynecol 1999;12:71-7.

Wiebe ER. Comparing abortion induced with methotrexate and misoprostol to methotrexate alone. Contraception 1999;59:7-10.

Rawling M, Wiebe ER. Pain control in abortion clinics. Int J Gynecol Obstet 1998;60:293-5.

Wiebe ER, Rawling M. Vaginal misoprostol to prepare the cervix before first trimester abortion. Int J Gynecol Obstet 1998;60:175-6.

Wiebe ER, Janssen PJ. Management of spontaneous abortions in family practices and hospitals. Fam Med 1998;30:293-6.

Wiebe ER. Abortion induced with methotrexate and misoprostol: A comparison of various protocols. Contraception;1997;55:159-63.

Wiebe ER. Choosing between surgical abortions and medical abortions induced with methotrexate and misoprostol. Contraception 1997;55:67-71.

Wiebe ER, Rawling M, Janssen P. Comparison of the effectiveness of 0.5% and 1% lidocaine for first trimester abortions. Int J Gynecol Obstet.1996;55:71-2.

Wiebe ER. Abortions induced with methotrexate and misoprostol. Can Med Assoc J. 1996;154(2):165-70

Wiebe ER, Rawling M. Pain Control in abortion. Int J Gynec Obstet. 1995;50:41-46

Wiebe ER. Comparison of the efficacy of different local anesthetics and techniques of local anesthesia in therapeutic abortions. Am J Obstet Gynecol l992;167:131-4

Wiebe ER. Genital injuries in sexual assault victims. Can Med Assoc J. 1991;144(6)644,647

Wiebe, ER. Post-partum Misery: A family physician’s perspective. Can. Fam. Phys. 1990;36:1285-1287

Wiebe, ER. Retention of Products of Conception After Therapeutic Abortion. Can Med Assoc J l986;134:505